A Q1 2022 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$33B

Q1 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.7B+8.1% YoY

Gross Profit

$910M54.4% margin

Operating Income

$376M22.5% margin

Net Income

$283M16.9% margin

EPS (Diluted)

$0.93

QoQ Revenue Growth

+0.8%

Cash Flow

Operating Cash Flow

$255M

Free Cash Flow

$180M

Stock-Based Comp.

$44M

Balance Sheet

Total Assets

$10.3B

Total Liabilities

$5.2B

Stockholders' Equity

$5.2B

Cash & Equivalents

$1.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.7B	$1.5B	+8.1%
Gross Profit	$910M	$838M	+8.6%
Operating Income	$376M	$328M	+14.6%
Net Income	$283M	$288M	-1.7%

Revenue Segments

Life Sciences and Applied Markets

$976M58%

Agilent CrossLab

$359M21%

Diagnostics and Genomics

$339M20%

Geographic Segments

Americas

$637M38%

Asia Pacific

$586M35%

Europe

$451M27%